| 000 | 01903 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515122941.0 | ||
| 264 | 0 | _c20080909 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1086/589295 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGhanem, Khalil G | |
| 245 | 0 | 0 |
_aAntiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJul 2008 |
||
| 300 |
_a258-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFalse Negative Reactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacrolides _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aReagins _xblood |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSerologic Tests |
| 650 | 0 | 4 |
_aSyphilis _xcomplications |
| 650 | 0 | 4 |
_aTreponema pallidum _xisolation & purification |
| 700 | 1 | _aMoore, Richard D | |
| 700 | 1 | _aRompalo, Anne M | |
| 700 | 1 | _aErbelding, Emily J | |
| 700 | 1 | _aZenilman, Jonathan M | |
| 700 | 1 | _aGebo, Kelly A | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 47 _gno. 2 _gp. 258-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/589295 _zAvailable from publisher's website |
| 999 |
_c18019034 _d18019034 |
||